Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of McKesson Co. (NYSE:MCK). In a filing disclosed on February 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in McKesson stock on January 24th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of ICF International (NASDAQ:ICFI) on 2/3/2025.
- Purchased $15,001 – $50,000 in shares of CACI International (NYSE:CACI) on 1/31/2025.
- Purchased $50,001 – $100,000 in shares of Hawaiian Electric Industries (NYSE:HE) on 1/31/2025.
- Sold $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 1/30/2025.
- Purchased $1,001 – $15,000 in shares of Intuitive Surgical (NASDAQ:ISRG) on 1/30/2025.
- Purchased $1,001 – $15,000 in shares of Agios Pharmaceuticals (NASDAQ:AGIO) on 1/29/2025.
- Purchased $1,001 – $15,000 in shares of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/29/2025.
- Purchased $1,001 – $15,000 in shares of Paragon 28 (NYSE:FNA) on 1/29/2025.
- Purchased $1,001 – $15,000 in shares of U.S. Physical Therapy (NYSE:USPH) on 1/29/2025.
- Purchased $1,001 – $15,000 in shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 1/29/2025.
McKesson Stock Performance
MCK stock traded up $5.57 during trading on Thursday, hitting $600.57. 339,854 shares of the company’s stock traded hands, compared to its average volume of 749,308. The stock has a market capitalization of $76.24 billion, a price-to-earnings ratio of 27.50, a P/E/G ratio of 1.30 and a beta of 0.52. The business has a fifty day simple moving average of $587.56 and a 200 day simple moving average of $562.90. McKesson Co. has a 52 week low of $464.42 and a 52 week high of $637.51.
McKesson Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 3rd will be paid a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a yield of 0.47%. The ex-dividend date is Monday, March 3rd. McKesson’s payout ratio is presently 13.00%.
Insider Buying and Selling
In other McKesson news, EVP Leann B. Smith sold 579 shares of McKesson stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total value of $331,645.41. Following the transaction, the executive vice president now owns 864 shares in the company, valued at approximately $494,890.56. The trade was a 40.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.11% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
A number of analysts recently commented on the stock. Wells Fargo & Company lifted their target price on shares of McKesson from $535.00 to $641.00 and gave the stock an “equal weight” rating in a research note on Friday, December 13th. Citigroup decreased their target price on shares of McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a research report on Friday, January 10th. StockNews.com raised shares of McKesson from a “buy” rating to a “strong-buy” rating in a report on Thursday, February 6th. Mizuho began coverage on shares of McKesson in a report on Wednesday, December 4th. They issued a “neutral” rating and a $630.00 price target for the company. Finally, Bank of America lowered their price target on McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Two research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $645.79.
Read Our Latest Research Report on McKesson
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of MCK. Exchange Traded Concepts LLC grew its stake in shares of McKesson by 343.6% during the 3rd quarter. Exchange Traded Concepts LLC now owns 5,727 shares of the company’s stock valued at $2,832,000 after buying an additional 4,436 shares during the period. ORG Wealth Partners LLC acquired a new position in McKesson in the 3rd quarter worth $40,000. CX Institutional boosted its position in McKesson by 175.8% in the 3rd quarter. CX Institutional now owns 10,228 shares of the company’s stock valued at $5,057,000 after buying an additional 6,519 shares during the last quarter. Creative Planning grew its position in shares of McKesson by 2.1% during the third quarter. Creative Planning now owns 63,328 shares of the company’s stock worth $31,064,000 after buying an additional 1,316 shares in the last quarter. Finally, QV Investors Inc. lifted its holdings in McKesson by 0.6% during the 3rd quarter. QV Investors Inc. now owns 3,499 shares of the company’s stock worth $1,730,000 after buying an additional 20 shares during the last quarter. 85.07% of the stock is currently owned by institutional investors and hedge funds.
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
About McKesson
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Read More
- Five stocks we like better than McKesson
- Basic Materials Stocks Investing
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- There Are Different Types of Stock To Invest In
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- CVS Health: Earnings Beat Ignites Stock Rally
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.